AbbVie Inc. 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-18 4:15 pm Purchase | 2025-02-11 | 13G | Xilio Therapeutics, Inc. XLO | AbbVie Inc. ABBV | 4,347,826 9.000% | 4,347,826 (New Position) | Filing |